106 related articles for article (PubMed ID: 2274701)
1. Hemodynamic effects of long-term converting-enzyme inhibition in renal hypertensive rats.
Salom MG; Salazar FJ; Fenoy FJ; Pinilla JM; Marín N; Quesada T
Rev Esp Fisiol; 1990 Jun; 46(2):171-6. PubMed ID: 2274701
[TBL] [Abstract][Full Text] [Related]
2. [Hemodynamic changes in the acute phase of experimental hypertension].
Carbonell LF; Salazar J; García-Estañ J; Jiménez JL; Quesada T
Rev Esp Fisiol; 1983 Jun; 39(2):155-60. PubMed ID: 6622806
[TBL] [Abstract][Full Text] [Related]
3. Long-term cardiac effects of hypotensive agents in normotensive mature rats: comparison of beta-blocking agent and converting enzyme inhibition.
Azizi M; Levy B; Salzmann JL; Cerol ML; Poitevin P; Ménard J; Michel JB
J Cardiovasc Pharmacol; 1989 May; 13(5):691-701. PubMed ID: 2472516
[TBL] [Abstract][Full Text] [Related]
4. [Cardiovascular effects of peptide inhibitors of the renin-substrate reaction in rats with renovascular hypertension. Goldblatt: 2 kidneys--1 clip].
Labbé T; Bonoron-Adèle S; Geoffre S; Précigoux G; Laval M; Hospital M; Besse P
Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():183-7. PubMed ID: 3142405
[TBL] [Abstract][Full Text] [Related]
5. Graded regional vasodilation with converting enzyme inhibitors in conscious spontaneously hypertensive rats.
Lappe RW; Todt JA; Wendt RL
J Pharmacol Exp Ther; 1985 Dec; 235(3):651-6. PubMed ID: 3001271
[TBL] [Abstract][Full Text] [Related]
6. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
[TBL] [Abstract][Full Text] [Related]
7. Effects of converting-enzyme inhibitor on hemodynamic actions of ANP in renal hypertensive rats.
Salom MG; Fenoy FJ; Inglés AC; Martínez L; Quesada T
Am J Physiol; 1989 Aug; 257(2 Pt 2):R365-9. PubMed ID: 2527475
[TBL] [Abstract][Full Text] [Related]
8. Endogenous angiotensin II facilitates sympathetically mediated hemodynamic responses in pithed rats.
Kaufman LJ; Vollmer RR
J Pharmacol Exp Ther; 1985 Oct; 235(1):128-34. PubMed ID: 3900340
[TBL] [Abstract][Full Text] [Related]
9. [Anti-hypertensive action of Captopril. Hemodynamic study (author's transl)].
Levenson J; Simon A; Temmar M; Safar M
Nouv Presse Med; 1980 Feb; 9(9):617-9. PubMed ID: 6987622
[TBL] [Abstract][Full Text] [Related]
10. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
11. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.
Takeyama K; Minato H; Nakatsuji K; Suzuki H; Nose I; Oka M; Hosoki K; Hatano N; Kadokawa T
Arzneimittelforschung; 1986; 36(1):69-73. PubMed ID: 3513779
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
Trippodo NC; Robl JA; Asaad MM; Bird JE; Panchal BC; Schaeffer TR; Fox M; Giancarli MR; Cheung HS
J Pharmacol Exp Ther; 1995 Nov; 275(2):745-52. PubMed ID: 7473162
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic converting enzyme inhibition on the structure and function of large arteries in the rat.
Levy BI; Michel JB; Salzmann JL; Devissaguet M; Camilleri JP; Safar ME
Clin Exp Hypertens A; 1989; 11 Suppl 2():487-98. PubMed ID: 2605798
[TBL] [Abstract][Full Text] [Related]
14. Low-dose angiotensin II reduces urinary cyclic AMP excretion in spontaneously hypertensive, but not normotensive, rats: independence from hypertension and renal hemodynamic effects of angiotensin.
Jackson EK; Herzer WA; Mi Z; Vyas SJ; Kost CK
J Pharmacol Exp Ther; 1999 Oct; 291(1):115-23. PubMed ID: 10490894
[TBL] [Abstract][Full Text] [Related]
15. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans.
Giudicelli JF; Richer C; Richard C; Thuillez C
Am J Hypertens; 1991 Mar; 4(3 Pt 2):258S-262S. PubMed ID: 2043315
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure responses to substances interfering with nitric oxide formation, cyclooxygenase and converting enzyme activities and vasopressin V1 receptors blockade in conscious spontaneously hypertensive and normotensive rats.
Januszewicz A; Lapiński M; Styś T; Styś A; Loń S
Pol J Pharmacol; 1994; 46(3):153-61. PubMed ID: 8000447
[TBL] [Abstract][Full Text] [Related]
18. Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state.
DiPette DJ; Simpson K; Guntupalli J
Magnesium; 1987; 6(3):136-49. PubMed ID: 3626625
[TBL] [Abstract][Full Text] [Related]
19. Role of angiotensin I and glucagon in canine endotoxin shock: effect of converting enzyme inhibitor and prior immunization.
Manson NH; Hess ML
Circ Shock; 1984; 12(3):177-89. PubMed ID: 6325034
[TBL] [Abstract][Full Text] [Related]
20. Different hemodynamic response after acute diuresis in the normotensive and hypertensive state.
Charocopos F; Hatzinikolaou P; Dipetti D
J Pharmacol Exp Ther; 1982 May; 221(2):315-8. PubMed ID: 7042955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
